Latest Conference Articles

Dr Lametra Scott Discusses Cost, Formulary Guidance in Managing Sickle Cell Disease

Dr Lametra Scott Discusses Cost, Formulary Guidance in Managing Sickle Cell Disease

October 23rd 2020, 8:42pm

AMCP Nexus: The Academy of Managed Care Pharmacy Nexus

While sickle cell disease is not prevalent in the general population, the significant cost associated with the condition warrants action from payers and formulary decision makers to improve patient access and align cost with their budgetary goals.

Areas to Watch in Specialty Drug Pipeline Include Cancer, Orphan Drugs

Areas to Watch in Specialty Drug Pipeline Include Cancer, Orphan Drugs

October 23rd 2020, 8:35pm

AMCP Nexus: The Academy of Managed Care Pharmacy Nexus

In her presentation, Aimee Tharaldson, PhD, senior clinical pharmacist of emerging therapeutics at Express Scripts, discussed the upcoming pipeline of specialty drug approvals and their potential impact on the market.

Dr Aimee Tharaldson Outlines the Pipeline, Role of Emerging Specialty Medications

Dr Aimee Tharaldson Outlines the Pipeline, Role of Emerging Specialty Medications

October 23rd 2020, 6:45pm

AMCP Nexus: The Academy of Managed Care Pharmacy Nexus

In the current pipeline of specialty medications seeking approval, a majority of development lies within orphan drugs and cancer medications, said Aimee Tharaldson, PharmD, of Express Scripts.

Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate

Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate

October 23rd 2020, 3:00pm

Kidney Week

Vadadustat is an investigational drug belonging to a class known as hypoxia-inducible prolyl hydroxylase inhibitors (HIF-PHIs) for the treatment of anemia in chronic kidney disease.

Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD

Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD

October 23rd 2020, 2:30pm

Kidney Week

The investigational drug finerenone met its primary endpoint in FIDELIO-DKD of slowing progression of chronic kidney disease (CKD) in patients with type 2 diabetes and CKD, said Rajiv Agarwal, MD, MS, FASN, a professor of medicine at Indiana University School of Medicine and a staff physician at the Veterans Affairs Medical Center in Indianapolis, Indiana.

Understanding the Complicated Patchwork of State Drug Pricing Reform Legislation

Understanding the Complicated Patchwork of State Drug Pricing Reform Legislation

October 23rd 2020, 2:00pm

AMCP Nexus: The Academy of Managed Care Pharmacy Nexus

The pressure on state budgets exerted by new approvals of costly therapeutics has led many states to implement legislation aimed at regulating drug prices, but the success of these efforts is not uniform across the nation.

Communicating Bad News Effectively and Compassionately in the ICU

Communicating Bad News Effectively and Compassionately in the ICU

October 23rd 2020, 1:15pm

CHEST

During a session at CHEST 2020, Robyn Scatena, MD, director of critical care at Norwalk Hospital, outlined 2 communication models to help break bad news in the intensive care unit (ICU).

Risks of Developing Delirium in ICU Patients With COVID-19

Risks of Developing Delirium in ICU Patients With COVID-19

October 22nd 2020, 10:15pm

CHEST

Rates of delirium for patients in the intensive care unit (ICU) have skyrocketed in the coronavirus disease 2019 (COVID-19) pandemic, said Brenda Truman Pun, DNP, RN, director of data quality, Vanderbilt Critical Illness, Brain Dysfunction, and Survivorship Center.

Session Highlights Long-term Skeletal Effects of Kidney Diseases

Session Highlights Long-term Skeletal Effects of Kidney Diseases

October 22nd 2020, 9:30pm

Kidney Week

Experts presenting the American Society of Nephrology’s Kidney Week session entitled “From Kids to Adults: Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Across the Life Course,” outlined the detrimental effects of childhood CKD and other kidney diseases on long-term health.

Melissa Andel on Legislative Efforts, Unmet Needs for State-Level Prescription Drug Pricing Reform

Melissa Andel on Legislative Efforts, Unmet Needs for State-Level Prescription Drug Pricing Reform

October 22nd 2020, 8:54pm

AMCP Nexus: The Academy of Managed Care Pharmacy Nexus

Americans not covered by Medicaid should be aware of 2 key factors: the use of copay accumulators in commercial health plans and management of emerging high-cost specialty prescription drugs.